Evidence map›Paper›PMID 36519413›Full record

ArticleClinical science (London, England : 1979)2023

Sexual dimorphism in acute myocardial infarction-induced acute kidney injury: cardiorenal deteriorating effects of ovariectomy in premenopausal female mice.

Nada J Habeichi, Rana Ghali, Ali Mroueh, Abdullah Kaplan, Cynthia Tannous, Abdo Jurjus, Ghadir Amin, Mathias Mericskay, George W Booz, Ahmed El-Yazbi and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Dual Time-Dependent Effects of Interleukin-33 Administration on the Kidney Postmyocardial Infarction.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Nada J HabeichiDepartment of Signaling and Cardiovascular Pathophysiology, Université Paris-Saclay, Inserm, UMR-S 1180, Châtenay-Malabry, France.
Rana Ghali *Department of Pharmacology and Toxicology, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Ali Mroueh *Department of Pharmacology and Toxicology, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Abdullah KaplanDepartment of Pharmacology and Toxicology, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Cynthia TannousDepartment of Pharmacology and Toxicology, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Abdo JurjusDepartment of Anatomy, Cell Biology, and Physiology, American University of Beirut Medical Center, Beirut, Lebanon.
Ghadir AminDepartment of Pharmacology and Toxicology, American University of Beirut, Faculty of Medicine, Beirut, Lebanon.
Mathias MericskayDepartment of Signaling and Cardiovascular Pathophysiology, Université Paris-Saclay, Inserm, UMR-S 1180, Châtenay-Malabry, France.
George W BoozDepartment of Pharmacology and Toxicology, School of Medicine, University of Mississippi Medical Center, Jackson, MS, U.S.A.ORCID 0000-0003-1478-9615
Ahmed El-YazbiDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.ORCID 0000-0003-3432-3038
Fouad A ZoueinDepartment of Signaling and Cardiovascular Pathophysiology, Université Paris-Saclay, Inserm, UMR-S 1180, Châtenay-Malabry, France.ORCID 0000-0003-4451-804X
American University of Beirut · LBInserm · FRAmerican University of Beirut Medical Center · LBAlAlamein International University · EGUniversity of Mississippi Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute kidney injury (AKI) is a common complication of cardiovascular diseases (CVDs) in both males and females, increasing mortality rate substantially. Premenopausal females appear to be more protected, suggesting a potential protective role of female sex hormones. Here, we tested the hypothesis that ovariectomy (OVX) eliminates the beneficial effect of female sex on renal protection following acute myocardial infarction (MI). Seven days post-MI, both sexes exhibited worsened kidney function and a substantial decrease in total kidney NAD levels. Unlike MI female mice, MI males showed exacerbated morphological alterations with increased proinflammatory, proapoptotic, and profibrotic biomarkers. The expression of NAD+ biosynthetic enzymes NAMPT and NMRK-1 was increased in MI females only, while males showed a substantial increase in NAD+ consuming enzyme PARP-1. OVX did not eliminate the female-sex protection of glomerular morphology but was associated with swelling of proximal convoluted tubules with MI as in males. With OVX, MI females had enhanced proinflammatory cytokine release, and a further decrease in creatinine clearance and urine output was observed. Our findings suggest that MI induced AKI in both sexes with pre-menopausal female mice being more protected. Ovariectomy worsens aspects of AKI in females after MI, which may portend increased risk for development of chronic kidney disease.

Indexed as

Acute Kidney InjuryMyocardial InfarctionAnimalsFemaleHumansKidneyMaleMiceNADOvariectomySex CharacteristicsNADacute kidney injurycell deathmitochondria dysfunctionMyocardial infarctionoxidative stresstype I cardio-renal syndrome

Identifiers

PMID36519413
PMCPMC9816372
OpenAlexW4311579715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.